Transient Ischemic Attack Clinical Trials
2 recruiting trials for Transient Ischemic Attack. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Transient Ischemic Attack clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Saglik Bilimleri Universitesi (1), Ottawa Heart Institute Research Corporation (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is [18F]-Florbetaben PET and CT imaging (procedure, 1 trial).
Track Transient Ischemic Attack trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
TIA Scores' Mortality Predictions and Recurrent TIA and Stroke Prediction
Our study adopts a prospective design. Our research aims to determine the significance of ABCD2, ABCD3-I, Canadian TIA Score, and NIHSS Score in predicting the likelihood of...
Florbetaben for Imaging of Vascular Amyloid
The Primary Objective is to determine if a new nuclear tracer (named 18F-Florbetaben) used with nuclear imaging (PET imaging) can detect inflamed plaque in patients with recent...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Transient Ischemic Attack, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Transient Ischemic Attack, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Transient Ischemic Attack, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.